BioCentury
ARTICLE | Clinical News

Onapristone ER: Phase I/II amended

August 24, 2015 7:00 AM UTC

Arno amended and began the dose-expansion stage of an open-label, dose-escalation, U.K. Phase I/II trial evaluating 10, 20, 30, 40 and 50 mg oral onapristone ER twice daily with and without Zytiga ab...